Lamivit capsule 400 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

lamivit capsule 400 mg

vitapharm-com srl, im - laminaria saccharina - capsule - 400 mg

Citramon-forte comprimate 320 mg + 240 mg + 40 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

citramon-forte comprimate 320 mg + 240 mg + 40 mg

stirolbiofarm srl - acid acetylsalicylicum + paracetamolum + cofeina - comprimate - 320 mg + 240 mg + 40 mg

Hemoglovit sirop 17,5 mg + 3,5 mg/ml Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

hemoglovit sirop 17,5 mg + 3,5 mg/ml

vitapharm-com srl, im - de fier (iii) hydroxidum cu polymaltosi complex + viță de vie viniferae extract de semințe de - sirop - 17,5 mg + 3,5 mg/ml

Insert ovule 300 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

insert ovule 300 mg

farmaprim srl - sertoconazolum - ovule - 300 mg

Neurovit capsule 90 mg + 0,25 mg + 40 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

neurovit capsule 90 mg + 0,25 mg + 40 mg

vitapharm-com srl, im - pyridoxini hydrochloridum + cyanocobalaminum + benfothiaminum - capsule - 90 mg + 0,25 mg + 40 mg

Pantotin sirop 5% Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

pantotin sirop 5%

vitapharm-com srl, im - acidum hopantenicum - sirop - 5%

Proactiv capsule 100 mg + 25 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

proactiv capsule 100 mg + 25 mg

vitapharm-com srl, im - acidum ascorbicum + rutosidum - capsule - 100 mg + 25 mg

Biozar capsule 32 mg + 32 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

biozar capsule 32 mg + 32 mg

vitapharm-com srl, im - extract de rădăcină berberidis + extract de pietre betulae - capsule - 32 mg + 32 mg

Comirnaty Uniunea Europeană - română - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccinuri - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.

Ivabradine JensonR Uniunea Europeană - română - EMA (European Medicines Agency)

ivabradine jensonr

jensonr+ limited - clorhidrat de ivabradină - angina pectoris; heart failure - terapia cardiacă - tratamentul simptomatic al cronică stabilă angină pectorală la adulţi de boala coronariană cu ritm sinusal normal şi inima rata ≥ 70 bpm. ivabradine este indicat: - la adulţi în imposibilitatea de a tolera sau cu o contra-indicaţie la utilizarea de beta-blocante - sau in combinatie cu beta-blocante la pacienţii inadecvat controlate cu o doză optimă nonselectiv. tratamentul insuficienţei cardiace cronice ivabradine este indicată în insuficienţa cardiacă cronică ghergu ii la clasa iv cu disfuncţie sistolică, la pacienţii în ritm sinusal şi a cărui rată de inima este ≥ 75 bpm, în asociere cu terapia standard, inclusiv terapie beta-blocant sau când nonselectiv terapia este contraindicată sau nu tolerat.